25.4 C
September 25, 2023
Egypt Bulletin

EU endorses Pfizer-BioNTech COVID-19 vaccine for use in children

The European Commission on Friday authorized Pfizer-BioNTech COVID-19 vaccine for use in children as young as 12, paving the way for a broader roll-out in the bloc after similar clearances in the United States and Canada. The decision comes after European Medicines Agency (EMA) backed the use of the vaccine in 12- to 15-year olds earlier in the day. The agency’s endorsement came weeks after it began evaluating extending use of the vaccine to include that age group. The vaccine is already being used in the European Union for those aged 16 and above. 
EU endorses Pfizer-BioNTech COVID-19 vaccine for use in children

The EMA said two doses of the vaccine, branded as Comirnaty, were required in the 12-15 age group and should be administered with an interval of at least three weeks, the same as for adults, adding that it was up to individual EU states to decide if and when to offer the vaccine to teenagers. Distribution and administration of the vaccine by the EU member states will continue to be determined according to the populations identified in the EU and as per national guidance, Pfizer and BioNTech said.

Related posts

New Ebola outbreak declared in Democratic Republic of Congo

Monkeypox cases cross 14K globally, with 700 diagnosed in Netherlands

Nearly half of cancer deaths are caused by preventable factors

Within 24 hours, there were 3,398 COVID-19 cases in Russia, 39 deaths

New COVID model predicts one million deaths in China by 2023

WHO reports that tuberculosis cases are on the rise for the first time in years